Summary The expression of TGF-x in human colon and lung carcinoma cell lines has been reported previously, but its expression in primary tumours has not been described in detail. We have used the radio-immunoassay method to measure the specific content of immunoreactive TGF-x in the acid ethanol extracts of normal and cancerous tissues of human colon and lung. The average TGF-a content of colon carcinomas is 4 times that of the normal mucosa, and for non-small cell lung carcinomas it is twice that of the normal parenchyma. Because of variability in the TGF-x expression among individuals and in different segments of colon and lobes of lung, the ratio of TGF-a content of paired tumour and normal tissue was also calculated. On average, the tumour/normal ratio for colon carcinoma is higher than that for lung carcinoma. Transforming growth factor-alpha (TGF-a) was first isolated and identified as one of the components of the sarcomaderived growth factor that interacted with the receptor of epidermal growth factor (EGF) (Delarco & Todaro, 1978; Anzano et al., 1983) . Subsequent investigations revealed that the TGF-a molecule shared approximately 40% homology to the amino acid sequence of EGF (Marquardt et al., 1983; Marquardt et al., 1984) , and it appeared to exert its biological effects exclusively by interacting with the EGF receptors (Carpenter et al., 1983) . The initial findings of frequent expression of TGF-a in neoplastic or malignant but not in normal cell lines nor adult tissues, coupled with the demonstration of its expression in fetal/embryonic tissues in rats led to the suggestion that TGF-a represented an oncofetal counterpart of EGF (Goustin et al., 1986) . Recently, the expression of TGF-x has been demonstrated in several human normal adult cells/tissues including skin keratinocytes (Coffey et al., 1987b) , breast ductal epithelial cells (Zajchowski et al., 1988) , activated macrophages (Madtes et al., 1988; Rappolee et al., 1988) , gastrointestinal mucosa (Bennett et al., 1989; Cartlidge & Elder, 1989) , and kidney (Gomella et al., 1989) . TGF-a expression by human colonic and lung carcinoma cell lines has been reported previously (Coffey et al., 1987a; Hanauske et al., 1987; Watkins et al., 1988; Anzano et al., 1989; Derynck et al., 1987) but its expression and possible biological role in primary human lung and colonic carcinomas has not been studied systematically. We have used both the radioimmunoassay and nucleic acid hybridisation techniques to examine the expression of TGF-a in primary human colonic and lung carcinomas.
Transforming growth factor-alpha (TGF-a) was first isolated and identified as one of the components of the sarcomaderived growth factor that interacted with the receptor of epidermal growth factor (EGF) (Delarco & Todaro, 1978; Anzano et al., 1983) . Subsequent investigations revealed that the TGF-a molecule shared approximately 40% homology to the amino acid sequence of EGF (Marquardt et al., 1983; Marquardt et al., 1984) , and it appeared to exert its biological effects exclusively by interacting with the EGF receptors (Carpenter et al., 1983) . The initial findings of frequent expression of TGF-a in neoplastic or malignant but not in normal cell lines nor adult tissues, coupled with the demonstration of its expression in fetal/embryonic tissues in rats led to the suggestion that TGF-a represented an oncofetal counterpart of EGF (Goustin et al., 1986) . Recently, the expression of TGF-x has been demonstrated in several human normal adult cells/tissues including skin keratinocytes (Coffey et al., 1987b) , breast ductal epithelial cells (Zajchowski et al., 1988) , activated macrophages (Madtes et al., 1988; Rappolee et al., 1988) , gastrointestinal mucosa (Bennett et al., 1989; Cartlidge & Elder, 1989) , and kidney (Gomella et al., 1989) . TGF-a expression by human colonic and lung carcinoma cell lines has been reported previously (Coffey et al., 1987a; Hanauske et al., 1987; Watkins et al., 1988; Anzano et al., 1989; Derynck et al., 1987) but its expression and possible biological role in primary human lung and colonic carcinomas has not been studied systematically. We have used both the radioimmunoassay and nucleic acid hybridisation techniques to examine the expression of TGF-a in primary human colonic and lung carcinomas.
Materials and methods
Human colon and lung carcinoma tissues were obtained within 30 to 60 min after surgical resection. When enough tissue was available, grossly normal colonic mucosa at least 10 cm away from the edge of tumour and the posterior basal segment of the lobectomy specimen from each case was concurrently obtained and used as the paired 'normal/con- trast' tissue. Some normal mucosa, from colons resected for diverticular disease, was also obtained. The specimens were snap-frozen in liquid nitrogen and then stored at -80'C.
Extraction of TGFfrom tissues
The acid ethanol extraction procedure for tissue growth factors was performed exactly according to Roberts et al. (1980) . The final extracts were dialysed in distilled water, lyophilised and then reconstituted with 4 mM HCI.
Radioimmunoassay (RIA)
This was performed using a kit from BioTope (Seattle, Washington) and according to the instructions provided by the manufacturer. The antibody was rabbit anti-rat TGF-a antiserum which recognised both the high and low molecular weight forms of rat and human bio-active TGF-a. We have independently confirmed its non-cross reactivity with EGF. A standard curve was established using varying concentrations of synthetic mature rat TGF-x (BioTope, M.W. 5600) and 100 fsg of extract protein from each sample was used for the (Derynck et al., 1984 IXSSC, the membrane was blotted dry and exposed for 5-8 days at -80°C to XAR-5 Kodak X-ray film using an intensifying screen. Densitometric measurements were performed using the Hoefer GS-300 scanning densitometer. All TGF-a values were standardised with the level of P-actin expression as probed by cDNA from the 3'-untranslated region of human P-actin gene (Ponte et al., 1983 ).
Pathological evaluation
The pathology was reviewed without knowing the results of the biochemical measurements. In most cases, slides from 2 to 4 sections of the tumours were available for examination by one of us (MST). Classification of the histological type and degree of differentiation (grade) of tumours was based on the predominant finding observed.
Statistical analysis All statistical analyses were performed using the non-parametric Wilcoxon rank sum test for independent samples (McClare & Dietrich, 1988) . In some cases, Student's t-test was also performed.
Results
Although there was considerable variations among individuals (Figure 1 ), the acid ethanol extracts of both normal colonic mucosa and lung parenchyma contained approximately 0.8 ng immunoreactive TGF-a per 100 jig protein (Tables I and II (Table III) . The distribution of these T/N ratios is shown in Figure 2 TGF-o mRNA in these tissues (Figure 3) . However, in contrast to the radio-immunoassay findings, the relative expression of TGF-x mRNA in colon carcinomas is rarely much more than that of the contrasting normal mucosa (Figure 4) . Fewer than 20% of these tumours expressed 2 to 3 times more TGF-a mRNA than their corresponding normal mucosa. However, in 2 of 5 tumours whose TGF-x mRNA levels were twice as much, or more, than their contrasting normal mucosa, immunoreactive TGF-a content was also measured and found to be very high, indicating good correlation between high mRNA expression level and high level of TGF-a peptide in tumour tissues. A comparative study indicates that the level of TGF-a mRNA expression in these colonic tumours or normal mucosa is approximately one hundredth of that expressed by HT-29 colon carcinoma cell line (data not shown). (Rothbauer et al., 1989 All values have been normalised to the P-actin expression.
by Rothbauer et al. (1989) most likely also represented TGF-a. We have further demonstrated the presence of the full-length (4.6-4.8 Kb) TGF-a mRNA species in the total cellular RNA extracts of normal human colonic mucosa, thus further confirming the expression of this growth factor in normal adult colon. The expression of TGF-at in normal adult lung tissue has not been previously reported, although Nickell et al. (1983) have previously indicated its presence using the classical bioassay method of detecting TGFs. The mean immunoreactive TGF-x activity in normal lung parenchyma is comparable to that found in the colon. In contrast to a previous study which failed to show the presence of TGF-oc specific mRNA in normal lungs (Derynck et al., 1987) , we have demonstrated its presence in our study. With the continuing additions to the list of normal adult human tissues that express TGF-x, it appears that the role and importance of TGF-o in the growth and function of normal human adult tissues, especially epithelial cells requires re-evaluation.
Expression/secretion of TGF-c has been reported in most of the human colon carcinoma cell lines studied, but the levels of expression are highly variable (Anzano et al., 1989; Coffey et al., 1987a; Watkins et al., 1988; Hanauske et al., 1987 In contrast with the radio-immunoassay findings, significant over-expression of TGF-x mRNA in primary colon carcinoma tissues is rare. The highest over-expression in ,amour versus normal mucosa is 2-to 3-fold, and this is only seen in less than 20% of the specimens studied. This is different from renal cell carcinomas where more than 3-fold over-expression was found in 50% of cases (Gomella et al., 1989 Bergh (1988) has also reported that expression of TGF-a alone in non-small cell lung carcinoma cell lines could not be correlated with the extent of fibrosis in tumours formed by these cells in nude mice.
TGF-ax has been considered as one of the prototypes of an autocrine growth factor which may play important roles in carcinogenesis and tumour growth (Sporn & Todaro, 1980; Sporn & Roberts, 1985; Goustin et al., 1986; Derynck, 1988) .
TGF-a may also play an important role in tumour angiogenesis (Schreiber et al., 1986) , and in the pathogenesis of paraneoplastic hypercalcaemia (Ibbotson et al., 1986; Tashjian et al., 1985) . Nonetheless, the importance of TGF-c in tumour cell biology in vivo remains speculative, and our own analyses on colon and lung carcinomas have not provided further insights. Rothbauer et al. reported that in 2 of 3 patients with familial polyposis, the TGF-a levels in either the preneoplastic adenomatous polyps, or carcinoma, were actually lower than those in the 'normal' mucosa, suggesting that TGF-a expression is not related to the mechanism of multistage carcinogenesis. The introduction and expression of hTGF-a gene into mouse keratinocytes from normal skin or papillomas did not result in the formation of carcinoma, suggesting that this growth factor does not influence tumour progression directly (Finzi et al., 1988) . However, correlation of TGF-a synthesis or secretion with tumorigenicity and the pathological stage also cannot be demonstrated in human breast cancer cell lines/tissues (Dickson et al., 1986; Perroteau et al., 1986; Zajchowski et al., 1988; Ciardiello et al., 1989) . The marked heterogeneity of TGF-m expression, even among cancers of the same organ or histological type, suggests that it is unlikely to play a consistent and direct role in the pathogenesis of all cancers. However, TGF-o may still play an important indirect but synergistic role in the tumour biology of some individual human cancers, especially through its autocrine effects on cell proliferation and tumour growth rate, on pericellular matrix proteolysis involving the plasminogen activator systems (Laiho & Keski-Oja, 1989) , and through its paracrine effect on angiogenesis (Schreiber et al., 1986 ). Further knowledge on the level and pattern of expression of TGF-x in primary human cancers may also contribute understanding to its future use as a tumour marker (Yeh et al., 1987; Ciardiello et al., 1989) , prognostic indicator (Arteaga et al., 1988) and therapeutic target (Greig et al., 1988 
